BPR consortium management
>
As a recognised leader in BPR (Regulation (EU) No 528/2012) consortium management, ARCHE Consortia brings proven experience and a successful track record for both active substances and biocidal products. We have successfully submitted and evaluated several complex product family dossiers for consortia. We manage consortia on behalf of clients for both new and existing active substances (renewals).
For biocidal products, we actively launch calls for interest for upcoming BPR registrations related to various active substances and product types (PTs). The full list is available in the table below.
If you are interested in joining an ongoing biocidal product pre-consortium or responding to an open call for interest, we encourage you to express your interest as soon as possible in order to achieve the anticipated submission deadline! Early engagement benefits all participants by improving planning, cost-sharing, and regulatory success.
Active Substance
CAS n°
Product Type
Tentative Timeline
Contact
Status
7681-52-9
11, 12
BPC-opinion expected 2027/2028
Submission deadline 2029/2030
Ongoing pre-consortium
Can still join if of interest
7647-14-5
11
BPC-opinion expected end 2026
Submission deadline end 2028
Open call for interest
7782-50-5
11
BPC-opinion expected 2027/2028
Submission deadline 2029/2030
Open call for interest
87-90-1
2, 3, 4, 5, 11
BPC-opinion expected 2027/2028
Submission deadline 2029/2030
Open call for interest
-
2, 4, 5
Submitted June 2022
Submitted BPF dossier
7782-50-5
2, 5
Submitted December 2018
Authorised BPF dossier
7681-52-9
2, 3, 4
Submitted December 2018
Evaluated BPF dossier
7722-84-1
2, 4
Submitted January 2017
Submitted BPF dossier
79-21-0
2, 3, 4, 5
Submitted September 2017
Submitted BPF dossier
2893-78-9
51580-86-0
2, 3, 4, 5, 11
BPC-opinion expected 2027/2028
Submission deadline 2029/2030
No consortium due to limited overlap
Individual dossiers are developed
89997-63-7
18
Submission deadline 01/02/2025
No consortium due to limited overlap
Individual dossiers are developed
89997-63-7
18
Submission deadline 01/02/2025
No consortium due to limited overlap
Individual dossiers are developed
68424-85-1
1, 2, 3, 4
PT1: Submission deadline 01/07/2024
PT2: Submission deadline 01/07/2025
PT3-4: Submission deadline 01/11/2022
No consortium due to limited overlap
Individual dossiers are developed
7173-51-5
1, 2, 3, 4
PT1-2: Submission deadline 01/02/2024
PT3-4: Submission deadline 01/11/2022
No consortium due to limited overlap
Individual dossiers are developed
For more information, feel free to reach out to
Lieve Claeys
Regulatory Affairs Manager
European Registered Toxicologist
lieve.claeys@arche-consortia.be
+32 9 216 70 67